PPBT is Purple Biotech Ltd (Healthcare) — a non-dividend-paying stock. Trading at $1.75. Market cap: $3M.
Stock snapshot
| Price | $1.75 |
| Market cap | $3M |
| Sector | Healthcare |
| Exchange | NCM |
| Pays dividend | No |
About PPBT
Purple Biotech Ltd is a clinical-stage biotechnology company focused on the development and commercialization of pharmaceuticals. It currently have a preclinical tri-specific antibodies platform, CAPTN-3, with its therapeutic candidates, IM1240 and IM1305, and two other oncology therapeutic candidates that are in the clinical trial phase, CM24 and NT219, neither of which has been approved for marketing and are not being sold, marketed, or commercialized.
Related non-dividend companies
Other non-dividend stocks investors research alongside PPBT. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is PPBT's current stock price?
PPBT (Purple Biotech Ltd) is currently trading at $1.75.
Does PPBT pay a dividend?
PPBT (Purple Biotech Ltd) does not currently pay a regular dividend.
Track PPBT in DiviDrip
Add PPBT to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search PPBT and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-05. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.